Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi
-
Published:2021-07-30
Issue:10
Volume:100
Page:2547-2556
-
ISSN:0939-5555
-
Container-title:Annals of Hematology
-
language:en
-
Short-container-title:Ann Hematol
Author:
Santoro ArmandoORCID, Mazza Rita, Spina Michele, Califano Catello, Specchia Giorgina, Carella Michele, Consoli Ugo, Palombi Francesca, Musso Maurizio, Pulsoni Alessandro, Kovalchuk Sofya, Bonfichi Maurizio, Ricci Francesca, Fabbri Alberto, Liberati Anna Marina, Rodari Marcello, Giordano Laura, Chimienti Emanuela, Balzarotti Monica, Sorasio Roberto, Gallamini Andrea, Ghiggi Chiara, Ciammella Patrizia, Ricardi Umberto, Chauvie Stephane, Carlo-Stella Carmelo, Merli Francesco
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference29 articles.
1. Sasse S, Bröckelmann PJ, Goergen H, Plütschow A, Müller H, Kreissl S, Buerkle C, Borchmann S, Fuchs M, Borchmann P, Diehl V, Engert A (2017) Long-term follow-up of contemporary treatment in early-stage Hodgkin lymphoma: updated analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 trials. J Clin Oncol 35(18):1999–2007. https://doi.org/10.1200/JCO.2016.70.9410 2. Fermé C, Eghbali H, Meerwaldt JH, Rieux C, Bosq J, Berger F, Girinsky T, Brice P, van’t Veer MB, Walewski JA, Lederlin P, Tirelli U, Carde P, Van den Neste E, Gyan E, Monconduit M, Diviné M, Raemaekers JM, Salles G, Noordijk EM, Creemers GJ, Gabarre J, Hagenbeek A, Reman O, Blanc M, Thomas J, Vié B, Kluin-Nelemans JC, Viseu F, Baars JW, Poortmans P, Lugtenburg PJ, Carrie C, Jaubert J, Henry-Amar M, EORTC-GELA H8 Trial (2007) Chemotherapy plus involved-field radiation in early-stage Hodgkin’s disease. N Engl J Med 357(19):1916–27. https://doi.org/10.1056/NEJMoa064601 3. Engert A, Schiller P, Josting A, Herrmann R, Koch P, Sieber M, Boissevain F, De Wit M, Mezger J, Duhmke E, Willich N, Muller RP, Schmidt BF, Renner H, Muller-Hermelink HK, Pfistner B, Wolf J, Hasenclever D, Loffler M, Diehl V, German Hodgkin’s Lymphoma Study Group (2003) Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin’s lymphoma: results of the HD8 trial of the German Hodgkin’s Lymphoma Study Group. J Clin Oncol 21(19):3601–8. https://doi.org/10.1200/JCO.2003.03.023 4. Borchmann P, Eichenauer DA, Pluetschow A (2015) Targeted BEACOPP variants in patients with newly diagnosed advanced stage classical Hodgkin lymphoma: final analysis of a randomized phase II study. Blood 126:580. https://doi.org/10.1182/blood.V126.23.580.580 5. Hasenclever D, Loeffler M, Diehl V (1996) Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin’s disease. German Hodgkin’s Lymphoma Study Group. Ann Oncol 7(Suppl 4):95–98. https://doi.org/10.1093/annonc/7.suppl_4.S95
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|